Cingulate (CING) News Today → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free CING Stock Alerts $0.80 +0.01 (+1.19%) (As of 03:33 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 21 at 9:59 AM | finance.yahoo.comFDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHDMay 20 at 2:05 PM | msn.comResearchers discover top-down signals in brain circuits regulating depressionMay 13, 2024 | msn.comRelationship found between creatine in the brain and recovery from traumatic stressMay 8, 2024 | investorplace.comCING Stock Earnings: Cingulate Beats EPS for Q1 2024May 8, 2024 | markets.businessinsider.comCingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business UpdateMay 8, 2024 | globenewswire.comCingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business UpdateMay 7, 2024 | msn.comMarijuana Users May Have More EmpathyMay 6, 2024 | msn.com7 Common Misconceptions About OCDMay 2, 2024 | msn.comThe Gift of Experiencing ‘Ego Death’April 30, 2024 | globenewswire.comPeter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live AccessApril 24, 2024 | msn.comStress activates brain regions linked to alcohol use disorder differently for women than men, finds studyApril 18, 2024 | msn.comResearchers identify 45 distinct brain connectivity alterations linked to anorexia nervosaApril 16, 2024 | finance.yahoo.comCingulate to Participate in Planet MicroCap Showcase: Vegas 2024April 1, 2024 | bizjournals.comCingulate CEO talks about the pharmaceutical company's road ahead after tough 2023April 1, 2024 | globenewswire.comCingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business UpdateMarch 28, 2024 | yahoo.com5 Easy Secrets of Super Agers That Can Help You Live a Long and Happy LifeMarch 20, 2024 | bizjournals.comCingulate can add $3.5M to latest stock offering as it navigates FDA drug approvalMarch 19, 2024 | globenewswire.comCingulate to Participate in Benzinga All Live Access EventMarch 13, 2024 | msn.comADHD linked to unusual brain connectivity patterns in large-scale neuroimaging studyMarch 13, 2024 | msn.comBreakups Can Actually Change Your Brain Chemistry—Here's HowMarch 12, 2024 | nz.news.yahoo.comWhy you can't focus and what science says can helpMarch 12, 2024 | sg.news.yahoo.comHere's why you can't focus - and science-backed ways to help youMarch 11, 2024 | msn.comSelf-hypnosis is soaring in popularity RN - I tried it after hearing that it could boost your mood and mental health from homeMarch 6, 2024 | globenewswire.comCingulate to Attend DCAT Week 2024 in New York CityFebruary 28, 2024 | bizjournals.comCingulate regains compliance with Nasdaq, maintaining key capital sourceFebruary 25, 2024 | msn.comUsing deep brain stimulation to map dysfunctional brain circuits linked to four disordersFebruary 22, 2024 | foxnews.comNew York woman reports improved mental health after undergoing brain electrode therapyFebruary 22, 2024 | msn.comBrain Pacemaker? New Stimulation Device Tested to Treat Depression Shows Promising ResultsFebruary 22, 2024 | msn.comResearchers use deep brain stimulation to map therapeutic targets for four brain disordersFebruary 22, 2024 | msn.comWoman Says Experimental Brain Implant Helped Her Lifelong Depression: 'Continuous Prozac'February 21, 2024 | dailymail.co.ukA pacemaker for the brain helped a woman with crippling depression. It may soon be available to moreFebruary 18, 2024 | msn.comAdditional study shows promise for low-intensity ultrasound as a non-invasive approach to alleviate painFebruary 14, 2024 | bizjournals.comCingulate adds three new members to board, following exits in DecemberFebruary 14, 2024 | msn.comMaltreatment linked to altered brain structure and spontaneous thought patterns in children, study findsFebruary 13, 2024 | finance.yahoo.comCingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of DirectorsFebruary 8, 2024 | bizjournals.comPharma company Cingulate raises $7.5M from public offeringFebruary 6, 2024 | markets.businessinsider.comCingulate Announces Closing of $7.5 Million Public OfferingFebruary 5, 2024 | msn.comBullied teens' brains show chemical change associated with psychosisFebruary 5, 2024 | msn.comBullying May Leave Teens at Greater Risk of PsychosisFebruary 5, 2024 | benzinga.comPeering Into Cingulate's Recent Short InterestFebruary 3, 2024 | seekingalpha.comCINGW Cingulate Inc. WT EXP 121026February 2, 2024 | msn.comU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.35%February 2, 2024 | bizjournals.comCingulate sets a $7.5M goal for its latest public stock offeringFebruary 2, 2024 | marketwatch.comCingulate Shares Drop 43% After Public Offering PricesFebruary 2, 2024 | markets.businessinsider.comCingulate Prices Offering Of 3.75 Mln Shares At $2/Share, Stock TanksFebruary 2, 2024 | finance.yahoo.comCingulate Announces Pricing of $7.5 Million Public OfferingFebruary 1, 2024 | marketbeat.comTrading was temporarily halted for "CING" at 10:02 AM with a stated reason of "LULD pause."February 1, 2024 | marketbeat.comTrading was temporarily halted for "CING" at 10:02 AM with a stated reason of "LULD pause."January 29, 2024 | bizjournals.comCingulate promotes exec to CFO amid dwindling capitalJanuary 29, 2024 | finanznachrichten.deCingulate Inc.: Longtime Cingulate Controller Jennifer Callahan Promoted to CFO Get Cingulate News Delivered to You Automatically Sign up to receive the latest news and ratings for CING and its competitors with MarketBeat's FREE daily newsletter. Email Address Everybody laughed when he recommended Netflix (Ad)"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. CING Media Mentions By Week CING Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CING News Sentiment▼-0.430.44▲Average Medical News Sentiment CING News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CING Articles This Week▼22▲CING Articles Average Week Get Cingulate News Delivered to You Automatically Sign up to receive the latest news and ratings for CING and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kazia Therapeutics News Today China Pharma News Today Kintara Therapeutics News Today NexImmune News Today Bright Minds Biosciences News Today Synaptogenix News Today TFF Pharmaceuticals News Today TransCode Therapeutics News Today Artelo Biosciences News Today GT Biopharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CING) was last updated on 5/21/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceElon to Transform U.S. Economy? Porter & Company Former CIA advisor: Dark side of AI now startingParadigm PressWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.